Asperlicin is a mycotoxin, derived from the fungus Aspergillus alliaceus. It acts as a selective antagonist for the cholecystokinin receptor CCKA, and has been used as a lead compound for the development of a number of novel CCKA antagonists with potential clinical applications. He et al. 1998 present a synthesis from aryl iodide and vinyl iodide.
{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 477368915 | ImageFile=Asperlicin structure.svg | ImageClass = skin-invert-image | ImageSize=240px | PIN=(7S)-7-{[(2S,9S,9aS)-9-Hydroxy-2-(2-methylpropyl)-3-oxo-2,3,9,9a-tetrahydro-1H-imidazo[1,2-a]indol-9-yl]methyl}-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione | OtherNames=
| Section1=
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).